Status:
COMPLETED
Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences
Lead Sponsor:
University Hospital Erlangen
Conditions:
Hypohidrotic Ectodermal Dysplasia
Eligibility:
All Genders
Brief Summary
Longitudinal study of 56 households with at least one member who had COVID-19 to compare the course of illness, immune responses, and long-term consequences of SARS-CoV-2 infection in HED patients wit...
Eligibility Criteria
Inclusion
- household with one or more members registered as patient(s) in the University Hospital Erlangen
- at least one person \<18 years of age
- at least one household member who has or had a SARS-CoV-2 infection confirmed by a positive PCR test, detection of specific antibodies against this virus, or by development of COVID-19 symptoms after being in close contact with a person known to be infected with SARS-CoV-2
- informed consent
Exclusion
- missing informed consent of one or more household members
- language barriers to communication that would prevent informed consent
Key Trial Info
Start Date :
June 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
231 Patients enrolled
Trial Details
Trial ID
NCT04741412
Start Date
June 3 2020
End Date
May 31 2021
Last Update
August 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Erlangen
Erlangen, Germany